По алфавиту
O F Hidalgo, J M Aramendía, G Alonso, J G Foncillas, A Brugarolas
Results of two sequential phase II studies of interleukin-2 (IL2) in metastatic renal cell carcinoma and melanoma: high-dose continuous intravenous IL2 infusion and subcutaneous IL2 administration in combination with alpha interferonRev Med Univ Navarra. Jul-Sep 1996;40(3):6-12.
Odak I, Barros-Martins J, Bošnjak B et al.
Reappearance of effector T cells is associated with recovery from COVID-19.EBioMedicine. 2020 Jul;57:102885. doi: 10.1016/j.ebiom.2020.102885. Epub 2020 Jul 7. PMID: 32650275; PMCID: PMC7338277.
Okada K, Nannmark U, Vujanovic NL, Watkins S, Basse P, Herberman RB, Whiteside TL.
Elimination of established liver metastases by human interleukin 2-activated natural killer cells after locoregional or systemic adoptive transfer.Cancer Res. 1996 Apr 1;56(7):1599-608. PMID: 8603408.
Ortaldo JR, Mason AT, Gerard JP et al.
Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.J Immunol. 1984 Aug;133(2):779-83. PMID: 6203980.
Oshimi K., Oshimi Y., Akutsu M. et al.
Cytotoxicity of interleukin 2-activated lymphocytes for leukemia and lymphoma cells.Blood (1986) 68 (4): 938-948.
Otani K., Ishikawa T., Aizawa Y. et al.
A Long-Term Survival Case of Liver Epithelioid Hemangioendothelioma With Multiple Lung Metastases That Regressed by Long-Term Administration of interleukin-2Nihon Shokakibyo Gakkai Zasshi. 2012 Dec;109(12):2097-102.
В соответствии с п. 1 ст. 64 Федерального закона от 12.04.2010 № 61-ФЗ "Об обращении лекарственных средств" лекарственные препараты, находящиеся в обращении на территории Российской Федерации, подлежат мониторингу безопасности в целях выявления возможных негативных последствий их применения, предупреждения пациентов и их защиты от применения таких препаратов.